Study in patients with moderate to severe plaque psoriasis to assess efficacy of secukinumab compared to Fumaderm®

Update Il y a 4 ans
Reference: EUCTR2014-005258-20

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To demonstrate the superiority of secukinumab compared to Fumaderm® in subjects with moderate to severe plaque psoriasis based on the proportion of PASI 75 responders at week 24.


Inclusion criteria

  • chronic moderate to severe plaque type psoriasis

Links